arrow_back Back to App

End Drug Price Gouging: Lower Medication Costs for All

This bill aims to lower prescription drug prices by setting maximum prices based on international rates. This means medications in federal programs, and for uninsured individuals, could become more affordable. Manufacturers who do not comply will face penalties, with collected funds directed towards new drug research.
Key points
Establishes maximum prescription drug prices based on international rates, potentially lowering costs for patients.
Lower drug prices will apply to federal health programs (e.g., Medicare, Medicaid) and all individuals, including the uninsured.
Drug manufacturers selling above the set price will face financial penalties, with funds supporting new drug research.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_HR_2829
Sponsor: Rep. Welch, Peter [D-VT-At Large]
Process start date: 2021-04-22
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

End Price Gouging for Medications Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_2829.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2021-04-22.

What are the main provisions?

Key points include:

  • Establishes maximum prescription drug prices based on international rates, potentially lowering costs for patients.
  • Lower drug prices will apply to federal health programs (e.g., Medicare, Medicaid) and all individuals, including the uninsured.
  • Drug manufacturers selling above the set price will face financial penalties, with funds supporting new drug research.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Welch, Peter [D-VT-At Large].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-27.

CATEGORIES

Health